| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/01/2013 | CN103071039A Medicine for treating aplastic anemia and preparation method |
| 05/01/2013 | CN103071028A Traditional Chinese medicinal composition for treating anaphylactoid purpura |
| 05/01/2013 | CN103070992A Medicine for treating high myopia macular hemorrhages |
| 05/01/2013 | CN103070944A Chinese medicinal composition for preventing and treating dam postpartum syndrome and preparation method thereof |
| 05/01/2013 | CN103070899A Method for separating and purifying total flavone of dandelion |
| 05/01/2013 | CN103070895A Preparation process of Chinese angelica ultrafine powder granule decoction piece |
| 05/01/2013 | CN103070850A Composition of oral solid medicine having good vivo behaviors |
| 05/01/2013 | CN103070822A Argatroban injection and preparation method thereof |
| 05/01/2013 | CN102643255B Andrographolide compound |
| 05/01/2013 | CN102406760B Herba verbenae officinalis fluid decoction pieces and preparation method thereof |
| 05/01/2013 | CN102363621B Cefminox sodium hexahydrate, preparation method thereof and pharmaceutical composition containing hexahydrate |
| 05/01/2013 | CN102357134B Medicine for preventing and treating Alzheimer disease and cerebral thrombosis and preparation method thereof |
| 05/01/2013 | CN102283997B Medicament for treating polycythemia vera, thrombocytosis and aplastic anemia |
| 05/01/2013 | CN102205000B Callicarpa nudiflora Hook. et Arn. extract, preparation method and application thereof |
| 05/01/2013 | CN101683522B Novel albumin-free factor VIII formulations |
| 04/30/2013 | US8431359 Nucleotide sequences coding tissue factor pathway inhibitor for use in treatment and prevention of blood disorders |
| 04/30/2013 | US8431149 Intravascular stent having an iridium oxide, gold, platinum, titanium or inert carbon coating, and a number or reservoirs with an antibiotic, anticoagulant, antiproliferative, bactericide, angiogenesis inhibitor, growth factor, or radionuclide; greater control of drug placement and coating durability |
| 04/30/2013 | US8431121 Specifically targeted catalytic antagonists and uses thereof |
| 04/30/2013 | CA2515608C Stem cell factor for preventing chemotherapy-induced depletion of blood cells |
| 04/30/2013 | CA2435664C Ncc2705-the genome of a bifidobacterium |
| 04/25/2013 | WO2013059469A1 Genetic alterations and methods of use thereof for the diagnosis and treatment of type i diabetes |
| 04/25/2013 | WO2013059347A1 Methods and compositions for treating ineffective erythropoiesis |
| 04/25/2013 | WO2013059213A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production |
| 04/25/2013 | WO2013058674A1 Bicarbonate haemodialysis solution |
| 04/25/2013 | WO2013057171A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/25/2013 | WO2013057167A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii |
| 04/25/2013 | WO2013056453A1 Preparation method and application of injection for needleless injection |
| 04/25/2013 | WO2013033366A3 Methods and compositions for promoting glucose homeostasis |
| 04/25/2013 | WO2013022982A3 Pegylated tyrosyl-trna synthetase polypeptides |
| 04/25/2013 | WO2012161559A3 A use of a composition comprising of acylated steryl glucoside in the manufacture of a product |
| 04/25/2013 | US20130102690 Collagen-polysaccharide materials mimicking blood vessels, tissues and bones for medical, pharmaceutical and orthopedic applications, and processes for producing the same |
| 04/25/2013 | US20130102657 Anti-angiogenic compositions and methods of use |
| 04/25/2013 | US20130101595 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 04/25/2013 | CA2852683A1 Methods and compositions for treating ineffective erythropoiesis |
| 04/25/2013 | CA2852397A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii |
| 04/25/2013 | CA2851057A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/24/2013 | EP2583965A1 Heterocyclic ring compound |
| 04/24/2013 | CN1630527B Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 04/24/2013 | CN103068383A Methods for the treatment or prophylaxis of thrombosis or embolism |
| 04/24/2013 | CN103059165A Polysaccharide acylate and preparation method thereof |
| 04/24/2013 | CN103059014A Novel heteroaryl amino derivative |
| 04/24/2013 | CN103058976A Quercetin alpha crystal-form substance, preparation method thereof, pharmaceutical composition thereof and purpose thereof |
| 04/24/2013 | CN103055343A Potato starch-hyaluronic acid composite hemostatic powder and preparation method thereof |
| 04/24/2013 | CN103055267A Traditional Chinese medicine for treating vertebra osteomyelitis |
| 04/24/2013 | CN103055195A Traditional Chinese medicine prescription for treating cold |
| 04/24/2013 | CN103055191A Preparation method and quality detection method of traditional Chinese medicine for treating hematuresis caused by nephritis |
| 04/24/2013 | CN103055186A External traditional Chinese medicine for treating ascites |
| 04/24/2013 | CN103055175A Traditional Chinese medicine composition for treating stranguria |
| 04/24/2013 | CN103055163A Traditional Chinese medicine composition used for preventing hemiplegia |
| 04/24/2013 | CN103055147A Plaster medicine used for treating chronic aplastic anemia, and preparation method thereof |
| 04/24/2013 | CN103055146A Plaster medicine used for treating chronic aplastic anemia, and preparation method thereof |
| 04/24/2013 | CN103055145A Traditional Chinese medicine composition for repairing organs |
| 04/24/2013 | CN103055124A Traditional Chinese medicine composition for treating myelofibrosis and preparation method thereof |
| 04/24/2013 | CN103055123A Traditional Chinese medicine composition for treating aplastic anemia and preparation method thereof |
| 04/24/2013 | CN103055102A Traditional Chinese medicine used for stopping bleeding, relieving pain and promoting tissue regeneration of wound |
| 04/24/2013 | CN103055085A Traditional Chinese medical preparation for treating iron-deficiency anemia |
| 04/24/2013 | CN103055078A Traditional Chinese medicine for treating ascites hepatoma and preparation method thereof |
| 04/24/2013 | CN103055070A Preparation method of traditional Chinese medicine treating subarachnoid hemorrhage |
| 04/24/2013 | CN103055036A Method for preparing medicament for treating leucopenia |
| 04/24/2013 | CN103055035A Pharmaceutical composition for treating leucopenia |
| 04/24/2013 | CN103055022A Method for processing rehmannia and application for rehmannia in preparation for medicine |
| 04/24/2013 | CN103055020A Freeze-dried radix rehmanniae recens for treating anaphylactoid purpura in children |
| 04/24/2013 | CN103055019A Freeze-dried radix rehmanniae recens for treating cerebral thrombus |
| 04/24/2013 | CN103054998A Compound coptis chinensis liquid |
| 04/24/2013 | CN103054976A Chinese medicinal composition for treating thrombopenia as well as preparation method and application of composition |
| 04/24/2013 | CN103054961A Application of Shenkang injection in preparation of medicament for treating chronic renal failure complication or complication caused by dialysis |
| 04/24/2013 | CN103054923A Method and device for carrying out dynamic and continuous circulating extraction on total triterpenoid saponin in yerbadetajo herb medicinal material |
| 04/24/2013 | CN103054922A Preparation technology of panax pseudoginseng ultrafine powder granular decoction pieces |
| 04/24/2013 | CN103054917A Application for freeze-dried purslane in medicine preparation |
| 04/24/2013 | CN103054905A Leech extract and its preparation method and use |
| 04/24/2013 | CN103054901A Dialysates and methods and systems related thereto |
| 04/24/2013 | CN103054892A Gracillin-hydroxypropyl-beta-cyclodextrin inclusion compound and preparation method thereof |
| 04/24/2013 | CN103054860A Solid preparation of benzenesulfonic acid prasugrel |
| 04/24/2013 | CN103054830A Soft capsule for treating nerve diseases |
| 04/24/2013 | CN103054816A Aprotinin freeze-dried powder and preparation method thereof |
| 04/24/2013 | CN103054805A Preparation method and application of injection for needle-free injection |
| 04/24/2013 | CN103054192A Healthcare cigarette holder |
| 04/24/2013 | CN102702061B Stachydrine hydrochloride compound and medicinal composition containing stachydrine hydrochloride compound |
| 04/24/2013 | CN102397365B Application of medicine composition in preparing medicines for controlling gynecologic diseases |
| 04/24/2013 | CN102380018B Cartialgenous incision hemostasis Chinese herbal medicament |
| 04/24/2013 | CN102337268B Human CTRP4 gene, its coding protein and their application |
| 04/24/2013 | CN102327515B Method for preparing traditional Chinese medicine (TCM) lotion for treating edema bedsore |
| 04/24/2013 | CN102319214B Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof |
| 04/24/2013 | CN102276754B Organosulfate glucan in hedysarum polybotys saccharide as well as preparation method and application thereof |
| 04/24/2013 | CN102274291B Chinese medicinal preparation for treating stroke and production method thereof |
| 04/24/2013 | CN102250736B Health-care medicated wine and preparation method thereof |
| 04/24/2013 | CN102077901B Swine hemoglobin enzymolysis and decoloration method |
| 04/24/2013 | CN101600446B Cellular preparations for use as a revascularisation stimulating agent |
| 04/24/2013 | CN101553475B Hydroxamates as inhibitors of histone deacetylase |
| 04/24/2013 | CN101501049B Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 04/24/2013 | CN101282968B Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 04/24/2013 | CN101267831B Compositions and methods for promoting hemostasis and other physiological activities |
| 04/23/2013 | CA2697081C 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 04/23/2013 | CA2694567C Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 04/23/2013 | CA2557989C Sulfated oligosaccharide derivatives |
| 04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/18/2013 | WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013056034A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013055985A1 Combinatorial compositions and methods of treating hemoglobinopathies |
| 04/18/2013 | WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |